APA (7th ed.) Citation

L, S., AM, S., K, T., W, W., & SK, L. (2024). Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice. Bioengineering & translational medicine, 9(5), e10651. https://doi.org/10.1002/btm2.10651

Chicago Style (17th ed.) Citation

L, Shen, Schaefer AM, Tiruthani K, Wolf W, and Lai SK. "Siglec15/TGF-β Bispecific Antibody Mediates Synergistic Anti-tumor Response Against 4T1 Triple Negative Breast Cancer in Mice." Bioengineering & Translational Medicine 9, no. 5 (2024): e10651. https://doi.org/10.1002/btm2.10651.

MLA (9th ed.) Citation

L, Shen, et al. "Siglec15/TGF-β Bispecific Antibody Mediates Synergistic Anti-tumor Response Against 4T1 Triple Negative Breast Cancer in Mice." Bioengineering & Translational Medicine, vol. 9, no. 5, 2024, p. e10651, https://doi.org/10.1002/btm2.10651.